Company Quick10K Filing
Maxwell Technologies
10-Q 2019-03-31 Filed 2019-05-01
10-K 2018-12-31 Filed 2019-02-14
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-07
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-02-16
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-08
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-03-01
10-Q 2016-09-30 Filed 2016-11-02
10-Q 2016-06-30 Filed 2016-08-03
10-Q 2016-03-31 Filed 2016-05-04
10-K 2015-12-31 Filed 2016-02-17
10-Q 2015-09-30 Filed 2015-10-29
10-Q 2015-06-30 Filed 2015-08-06
10-Q 2015-03-31 Filed 2015-04-23
10-K 2014-12-31 Filed 2015-02-12
10-Q 2014-09-30 Filed 2014-10-23
10-Q 2014-06-30 Filed 2014-07-31
10-Q 2014-03-31 Filed 2014-05-01
10-K 2013-12-31 Filed 2014-02-20
10-Q 2013-09-30 Filed 2013-10-24
10-Q 2013-06-30 Filed 2013-08-01
10-Q 2013-03-31 Filed 2013-08-01
10-K 2013-03-31 Filed 2013-08-01
10-Q 2012-09-30 Filed 2012-10-30
10-Q 2012-06-30 Filed 2012-08-02
10-Q 2012-03-31 Filed 2012-04-26
10-K 2011-12-31 Filed 2012-02-16
10-Q 2011-09-30 Filed 2011-11-07
10-Q 2011-06-30 Filed 2011-08-08
10-Q 2011-03-31 Filed 2011-05-05
10-K 2010-12-31 Filed 2011-03-10
10-Q 2010-09-30 Filed 2010-11-09
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-04
10-K 2009-12-31 Filed 2010-03-05
8-K 2019-05-16
8-K 2019-02-03
8-K 2019-01-15
8-K 2018-12-19
8-K 2018-12-19
8-K 2018-11-06
8-K 2018-08-07
8-K 2018-08-06
8-K 2018-05-15
8-K 2018-05-08
8-K 2018-04-18
8-K 2018-03-14
8-K 2018-02-15

Maxwell Technologies Financials

MXWL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302013-03-312013-06-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash29,79130,98829,28930,62822,31020,07328,73934,57130,64731,58530,74830,79824,73223,10125,03124,81324,38221,58935,67527,80225,35920,89419,18152,85250,12240,10321,54723,56158,02848,128
Accounts Receivable35,79131,83836,13143,14748,51452,99833,42035,21729,86937,62839,85030,63643,69832,17431,85736,29743,17228,11025,87420,66120,44124,05330,33127,14231,64332,39129,72330,02219,96618,153
Inventory26,91127,96527,23230,60630,21731,93041,62039,43544,73645,00344,97352,00944,85643,23841,14740,84139,05529,20032,95534,93932,24830,41630,17431,59932,22837,48541,63739,62133,64536,886
PP&E24,95226,98528,54131,92233,27535,80693,17039,519100,47743,74642,19241,018103,70237,91335,84733,355107,72231,51230,42828,97894,37524,72127,21726,069105,45930,17430,45331,30889,99823,344
Assets156,014154,189156,936173,050169,869176,234176,472188,824190,087199,402199,145193,156186,600171,020170,582171,857172,013158,435160,132148,598140,874137,901168,603197,821205,379204,676184,717187,118163,731161,879
Accounts Payable14,76215,35612,54422,29113,109
Long-Term Debt2,5042,292683,5413,3892,96083751008365442015,3005,900594944365643345730,17135,12435,55635,99736,45437,96938,305
Liabilities50,79150,90653,60554,10550,74750,08751,53960,91649,87756,61056,05559,13859,64749,43844,82048,83852,83743,15642,28435,70840,05243,82654,91589,31699,278101,61094,06380,99973,14085,942
Stockholders' Equity105,223103,283103,331118,945119,122126,147124,933127,908140,210142,792143,090134,018126,953121,582125,762123,019119,176115,279117,848112,890100,82294,075113,688108,505106,101103,06690,654106,11990,59175,937
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302013-03-312013-06-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Revenue38,46341,09642,49339,23040,85643,90744,50355,61038,97946,00146,07441,59352,91834,67037,79645,07649,83035,20334,13525,50626,40026,68637,10335,81630,76328,41629,46433,72715,438
Cost of Revenue22,98724,54726,34523,09323,87625,53421,70334,03424,60528,13129,47426,12334,41824,28425,64330,82035,58025,55024,15417,87820,69220,49529,27628,42023,38222,73524,03627,35716,966
Gross Profit15,47616,54916,14816,13716,98018,37317,22921,57614,37417,87020,09615,47018,50010,38612,15314,25614,2509,6539,9817,6285,7086,1917,8277,3967,3815,6815,4286,370-1,528
R&D5,2975,7075,3545,5965,2945,0845,7265,3786,1716,2236,9237,0037,9185,9305,7815,0685,6075,4615,1934,6284,6864,4304,8914,3445,5325,5495,5995,165
SG&A11,7479,5448,5169,2358,1877,2938,94116,19710,93910,94410,82311,15111,36810,1429,07010,58910,0988,2238,3749,5869,54012,07014,5149,6949,5729,7879,0529,700
Tax-4279226357147194704467493975819622,4063472,9558654364836008242,2381,2081,382527540-1,02230036414
Net Income-1,2172981,5725042,8645,4032,8673,405-2,814319-1,181-3,292-2,118-9,341-9,376-1,449-2,167-6,8482,167-6,855-12,169-10,399-10,118-13,860-8,752-9,205-11,302-9,723-17,620
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302013-03-312013-06-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash Operating5,8721,989-11,807-2,2272,44110,4479,512258-8856,878-12,414-7771,9017,406850-1,594-5,394-6,995-374-3,825-2,677-2,274-6,230-11,211-14,790-14,045-9,033
Cash Investing-3,703-3,472-4,057-4,231-4,833-2,079-6,801-1,985-891-2,319-1,780-1,275-942-562-1,364-2,15419,144-1,060-1,267-945288-1,235-2,502-3,910-3,929-1,861-702
Cash Financing1,43823216,294-139-114-472-2,2262,1791,058-1416,4675072-5,874-14335557-7-89-1018737,3255,7834,99222017,966-232